Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|19|8|611-621

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.19, Iss.8, 2018-07, pp. : 611-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel inhibitors in development for hepatocellular carcinoma

By Wörns Marcus Alexander   Galle Peter Robert  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 615-629

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Drug Targeting of RNA

By  

Frontiers in Drug Design & Discovery, Vol. 1, Iss. 1, 2005-01 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Large Intervening Non-coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression

By Geng YJ   Xie SL   Li Q   Ma J   Wang GY  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2119-2128

Field House Publishing

Access to resources Recommend Favorite

HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA

By Lim Lucy   Tran Bang Manh   Vincan Elizabeth   Locarnini Stephen   Warner Nadia  

Future Virology, Vol. 7, Iss. 12, 2012-12 ,pp. : 1237-1249

Future Medicine

Access to resources Recommend Favorite

Small Activating RNAs: Towards Development of New Therapeutic Agents and Clinical Treatments

By  

Current Pharmaceutical Biotechnology, Vol. 19, Iss. 8, 2018-07 ,pp. : 622-630

Bentham Science Publishers

Access to resources Recommend Favorite